JVI Figure table search 04
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Karlsson, I.
Right arrow Articles by Margolis, L. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Karlsson, I.
Right arrow Articles by Margolis, L. B.
Journal of Virology, September 2005, p. 11151-11160, Vol. 79, No. 17
0022-538X/05/$08.00+0     doi:10.1128/JVI.79.17.11151-11160.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.

Differential Pathogenesis of Primary CCR5-Using Human Immunodeficiency Virus Type 1 Isolates in Ex Vivo Human Lymphoid Tissue

Ingrid Karlsson,1* Jean-Charles Grivel,2 Silvia Sihui Chen,2,3 Anders Karlsson,4 Jan Albert,5 Eva Maria Fenyö,1 and Leonid B. Margolis2

Unit of Virology, Division of Medical Microbiology, Department of Laboratory Medicine, Lund University, Lund, Sweden,1 Laboratory of Cellular and Molecular Biophysics and National Institute of Child Health and Human Development,2 NASA/NIH Center for Three-Dimensional Tissue Culture, National Institutes of Health, Bethesda, Maryland;,3 Venhälsan, Karolinska University Hospital, Stockholm, Sweden,4 Swedish Institute for Infectious Disease Control and Microbiology and Tumorbiology Center, Karolinska Institute, Stockholm, Sweden5

Received 23 February 2005/ Accepted 25 May 2005

In the course of human immunodeficiency virus (HIV) disease, CCR5-utilizing HIV type 1 (HIV-1) variants (R5), which typically transmit infection and dominate its early stages, persist in approximately half of the infected individuals (nonswitch virus patients), while in the other half (switch virus patients), viruses using CXCR4 (X4 or R5X4) emerge, leading to rapid disease progression. Here, we used a system of ex vivo tonsillar tissue to compare the pathogeneses of sequential primary R5 HIV-1 isolates from patients in these two categories. The absolute replicative capacities of HIV-1 isolates seemed to be controlled by tissue factors. In contrast, the replication level hierarchy among sequential isolates and the levels of CCR5+ CD4+ T-cell depletion caused by the R5 isolates seemed to be controlled by viral factors. R5 viruses isolated from nonswitch virus patients depleted more target cells than R5 viruses isolated from switch virus patients. The high depletion of CCR5+ cells by HIV-1 isolates from nonswitch virus patients may explain the steady decline of CD4+ T cells in patients with continuous dominance of R5 HIV-1. The level of R5 pathogenicity, as measured in ex vivo lymphoid tissue, may have a predictive value reflecting whether, in an infected individual, X4 HIV-1 will eventually dominate.


* Corresponding author. Mailing address: Division of Medical Microbiology, Department of Laboratory Medicine, Lund University, Sölvegatan 23, 223 62 Lund, Sweden. Phone: 46 46 173271. Fax: 46 46 176033. E-mail: Ingrid.Karlsson{at}mmb.lu.se.


Journal of Virology, September 2005, p. 11151-11160, Vol. 79, No. 17
0022-538X/05/$08.00+0     doi:10.1128/JVI.79.17.11151-11160.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
J. Bacteriol. Mol. Cell. Biol. Microbiol. Mol. Biol. Rev.
Clin. Vaccine Immunol. ALL ASM JOURNALS

Copyright © 2005 by the American Society for Microbiology. All rights reserved.